Louisiana State Employees Retirement System’s Apellis Pharmaceuticals APLS Stock Holding History

Louisiana State Employees Retirement System’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,400	Closed	-$1.83M	–	1526
2026 Q1	$1.83M	Buy	+45,400	New	+$978K	0.03%	600

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Louisiana State Employees Retirement System's APLS Position: Q2 2026 in Review

Louisiana State Employees Retirement System sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 45,400 shares — an estimated $1.83M sold.

Louisiana State Employees Retirement System first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $1.83M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Louisiana State Employees Retirement System reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Louisiana State Employees Retirement System sold 45,400 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.83M.
Louisiana State Employees Retirement System first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Louisiana State Employees Retirement System's Apellis Pharmaceuticals position peaked at $1.83M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.